; and (B) by striking 12/31/2020 and inserting 12/31/2025 . (164) Fluopyram and prothioconazole formulations Heading 9902.09.58 is amended— (A) by amending the article description to read as follows: Product mixtures containing N-[2-[3-chloro-5-(trifluoromethyl)pyridin-2-yl]ethyl]-2-(trifluoromethyl) benzamide (Fluopyram) (CAS No. 658066–35–4) and (RS)-2-[2-(1-chlorocyclopropyl)-3-(2-chlorophenyl)-2-hydroxypropyl] -2,4-dihydro-1,2,4-triazole-3-thione (Prothioconazole) (CAS No. 178928–70–6) (provided for in subheading 3808.92.15) ; and (B) by striking 12/31/2020 and inserting 12/31/2025 . (165) Prothioconazole formulations Heading 9902.09.59 is amended— (A) by amending the article description to read as follows: Product mixtures containing 2-[2-(1-chlorocyclopropyl)-3-(2-chlorophenyl)-2-hydroxypropyl] -1,2-dihydro-3H-1,2,4-triazole-3-thione (Prothioconazole) (CAS No. 178928–70–6) (provided for in subheading 3808.92.15) ; and (B) by striking 12/31/2020 and inserting 12/31/2025 . (166) Fluopyram formulations Heading 9902.09.61 is amended— (A) by amending the article description to read as follows: Mixtures of N-[2-[3-chloro-5-(trifluoromethyl) pyridin-2-yl]ethyl]-2-(trifluoromethyl) benzamide (Fluopyram) (CAS No. 658066–35–4) (provided for in subheading 3808.92.15) ; and (B) by striking 12/31/2020 and inserting 12/31/2025 . (167) Fluopyram and imidacloprid formulations Heading 9902.09.62 is amended— (A) by amending the article description to read as follows: Mixtures of N-[2-[3-chloro-5-(trifluoromethyl) pyridin-2-yl]ethyl]-2-(trifluoromethyl) benzamide (Fluopyram) (CAS No. 658066–35–4) and N-[1-[(6-chloropyridin-3-yl)methyl]-4,5-dihydroimidazol-2-yl] nitramide (Imidacloprid) (CAS No. 138261–41–3) (provided for in subheading 3808.92.15)